Previously, LUTN prevents the progression of liver fibrosis induced by carbon tetrachloride-(CCL4) through targeting AKT/mTOR/p70S6K and TGFβ/Smad signaling pathways [26]. Here, RPS6KB1 is linked to Hepatic fibrosis.